Intra-operative technology improves lumpectomy procedures for many breast cancer patients
the ONA take:
A recently developed, intra-operative technology aids lumpectomy procedures by detecting microscopic amounts of cancer cells on tumor tissue.
These cancer cells are not typically visible during or after routine surgery. The MarginProbe system, manufactured and marketed by Dune Medical Devices, employs radio-frequency spectroscopy technology to detect cancer cells in the outer margins of removed tissue.
Dr. Freya Schnabel, Director of Breast Surgery at NYU Langone, led a multi-institutional retrospective study that evaluated nearly 600 patients that underwent lumpectomies for non-palpable breast malignancies. Dr. Schnabel utilized the new tool on approximately 50 patients, and the researchers concluded that the use of the MarginProbe system may as much as triple the odds of discovering additional cancer on removed tissue margins, when compared to more traditional intra-operative imaging.
In cases when cancerous cells are found in the margin tissue by the MarginProbe, the surgeon can remove additional tissue to be certain no cancer remains.
The use of this new tool could help surgeons determine that all cancer cells are excised during the initial surgery, sparing patients unnecessary additional procedures.
New intra-operative technology aids lumpectomy procedures by detecting microscopic amounts of cancer cells on tumor tissue.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- High Symptom Burden With Polycythemia Vera Linked to QoL Impairment
- Bioimpedence Spectroscopy Improves Early Detection of Breast Cancer-Related Lymphedema in At-Risk Patients
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- MRD Negativity Associated With Prolonged Survival in Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Patient Navigation Reduces Delays in Diagnostic Resolution
- Fee-for-service Medicare Plans Linked to Improved Care During Last Year of Life
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|